It has been demonstrated that several additional genetic alterations, which are engaged in epigenetic regulation, cell-growth signaling, and RNA splicing machinery, cooperate with JAK2, CALR, or MPL mutation for the transformation to AML from ET7–9. The gene discussed is MPL; the disease is acute myeloid leukemia.